| 1 | A1 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T3N0M0 | 2 |
| 1 | A2 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T3N0M0 | 3 |
| 1 | A3 | Human | F | 52 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | A4 | Human | F | 52 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | A5 | Human | F | 55 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 |
| 1 | A6 | Human | F | 55 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 |
| 1 | A7 | Human | F | 43 y | Cervix, Mucosa, Squamous epithelium (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | A8 | Human | F | 43 y | Cervix, Transitional epithelium (Cvx) | Adjacent normal with focal hyperplasia | Diseased | | |
| 1 | B1 | Human | F | 55 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | B2 | Human | F | 55 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | B3 | Human | F | 49 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | B4 | Human | F | 49 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | B5 | Human | F | 33 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | B6 | Human | F | 33 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | B7 | Human | F | 43 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | B8 | Human | F | 43 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | C1 | Human | F | 53 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1bN0M0 | 3 |
| 1 | C2 | Human | F | 53 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1bN0M0 | 3 |
| 1 | C3 | Human | F | 44 y | Cervix, Fibrous tissue and blood vessel (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | C4 | Human | F | 44 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | C5 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 |
| 1 | C6 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 |
| 1 | C7 | Human | F | 52 y | Cervix, Mucosa (Cvx) | Adjacent normal with severe chronic inflammation | Inflammatory | | |
| 1 | C8 | Human | F | 52 y | Cervix, Mucosa (Cvx) | Adjacent normal with severe chronic inflammation | Inflammatory | | |
| 1 | D1 | Human | F | 39 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | D2 | Human | F | 39 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | D3 | Human | F | 45 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | D4 | Human | F | 45 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | D5 | Human | F | 77 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 |
| 1 | D6 | Human | F | 77 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 |
| 1 | D7 | Human | F | 40 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | D8 | Human | F | 40 y | Cervix (Cvx) | Adjacent normal | Benign non-neoplastic | | |
| 1 | E1 | Human | F | 43 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | E2 | Human | F | 43 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 |
| 1 | E3 | Human | F | 38 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | E4 | Human | F | 38 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | E5 | Human | F | 41 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1b1N1M0 | 3 |
| 1 | E6 | Human | F | 41 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1b1N1M0 | 3 |
| 1 | E7 | Human | F | 48 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | E8 | Human | F | 48 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | F1 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N1M0 | 3 |
| 1 | F2 | Human | F | 37 y | Cervix (Cvx) | Squamous cell carcinoma | Malignant | T1N1M0 | 3 |
| 1 | F3 | Human | F | 42 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | F4 | Human | F | 42 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | F5 | Human | F | 51 y | Cervix (Cvx) | Adenocarcinoma | Malignant | T1aN0M0 | 2 |
| 1 | F6 | Human | F | 51 y | Cervix (Cvx) | Adenocarcinoma | Malignant | T1aN0M0 | 2 |
| 1 | F7 | Human | F | 42 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |
| 1 | F8 | Human | F | 42 y | Cervix, Canal, Mucosa (Cvx) | Adjacent normal with chronic inflammation | Inflammatory | | |